Breaking News Instant updates and real-time market news.

SBUX

Starbucks

$52.70

-0.34 (-0.64%)

, LMT

Lockheed Martin

$299.20

-2.22 (-0.74%)

20:02
08/20/17
08/20
20:02
08/20/17
20:02

On The Fly: Top five weekend stock stories

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. B&G Foods (BGS) has entered into a definitive agreement to acquire Back to Nature Foods Company from Brynwood Partners, Mondelez (MDLZ) and certain other entities and individuals for approximately $162.5M in cash. B&G Foods expects the acquisition to close during Q3 of 2017. 2. Sempra Energy (SRE) is nearing an agreement to buy Oncor Electric Delivery for about $9.3B, according to Bloomberg, citing people familiar with the matter. The Texas utility is also being pursued by Warren Buffett's Berkshire Hathaway (BRK.A) and Paul Singer's Elliott Management, the publication noted. 3. Starbucks' (SBUX) mobile order-and-pay feature has become a major hit, Alex Eule wrote in this week's edition of Barron's. In the last quarter, 9% of Starbucks' U.S. orders were placed in advance, and nearly a third of all its orders were paid for via the company's phone app, the publication noted. Eule believes that the stock could jump 20% or more over the next 12 months. 4. Lionsgate's (LGF.A) action comedy "Hitman's Bodyguard" debuted to a better than expected $21.6M from 3,377 theaters to top the weekend box-office chart, as summer revenue continues to tumble. The movie tells the story of a world-renowned bodyguard who is forced to protect an infamous hitman that is scheduled to testify. With a 38% rating on Rotten Tomatoes, "Hitman's Bodyguard" received a B+ CinemaScore rating by audiences. 5. Lockheed Martin (LMT), Gardner Denver (GDI), Cardinal Health (CAH), Patterson Companies (PDCO), ResMed (RMD), AmerisourceBergen (ABC), UnitedHealth (UNH), and Advance Auto Parts (AAP) saw positive mentions in Barron's, while Motorola Solutions (MSI) was mentioned cautiously.

SBUX

Starbucks

$52.70

-0.34 (-0.64%)

LMT

Lockheed Martin

$299.20

-2.22 (-0.74%)

GDI

Gardner Denver

$21.97

-0.03 (-0.14%)

CAH

Cardinal Health

$64.38

-0.78 (-1.20%)

PDCO

Patterson Companies

$36.45

-0.31 (-0.84%)

RMD

ResMed

$73.07

0.28 (0.38%)

ABC

AmerisourceBergen

$78.60

-1.34 (-1.68%)

UNH

UnitedHealth

$190.82

-1.88 (-0.98%)

AAP

Advance Auto Parts

$93.26

0.41 (0.44%)

MSI

Motorola Solutions

$87.37

0.24 (0.28%)

LGF.A

Lionsgate

$28.41

0.37 (1.32%)

BGS

B&G Foods

$31.40

-0.3 (-0.95%)

MDLZ

Mondelez

$42.94

-0.47 (-1.08%)

SRE

Sempra Energy

$116.55

0.76 (0.66%)

BRK.A

Berkshire Hathaway

$267,377.00

302 (0.11%)

  • 22

    Aug

  • 23

    Aug

  • 23

    Aug

  • 24

    Aug

  • 29

    Aug

  • 06

    Sep

  • 11

    Sep

  • 14

    Sep

  • 18

    Sep

  • 21

    Sep

  • 22

    Sep

  • 25

    Sep

  • 27

    Sep

  • 29

    Sep

  • 02

    Nov

  • 25

    Jan

SBUX Starbucks
$52.70

-0.34 (-0.64%)

08/09/17
08/09/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Starbucks (SBUX) downgraded on more cautious U.S. comp sales outlook at BMO Capital with analyst Andrew Strelzik saying he's "more cautious" on the outlook for the company's U.S. comparable sales, partly due to increased cannibalization of stores, increased competition, "throughput headwinds," and the possibility that "contributions from beverage innovation and food growth may have peaked." 2. Albemarle (ALB) downgraded to Hold from Buy at SunTrust with analyst James Sheehan citing recent share strength. 3. Dean Foods (DF) downgraded to Market Perform from Outperform at Wells Fargo with analyst John Baumgartnerm citing the second quarter miss and "big" guidance reduction. 4. Air Lease (AL) downgraded to Neutral from Buy at BofA/Merrill with analyst Kristine Liwag citing valuation. 5. AIG (AIG) downgraded to Neutral from Overweight at Atlantic Equities. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/09/17
BMOC
08/09/17
DOWNGRADE
BMOC
Market Perform
Starbucks downgraded on more cautious U.S. comp sales outlook at BMO Capital
As noted earlier, BMO Capital downgraded Starbucks to Market Perform from Outperform. Analyst Andrew Strelzik says he's "more cautious" on the outlook for the company's U.S. comp sales, partly due to increased cannibalization of stores, increased competition, "throughput headwinds," and the possibility that "contributions from beverage innovation and food growth may have peaked."
08/09/17
BMOC
08/09/17
DOWNGRADE
BMOC
Market Perform
Starbucks downgraded to Market Perform from Outperform at BMO Capital
07/28/17
07/28/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Starbucks (SBUX) was downgraded to Neutral from Buy at Guggenheim and to Hold from Buy at Stifel. 2. Spirit Airlines (SAVE) was downgraded to Neutral from Buy at Buckingham and BofA/Merrill and to In-Line from Outperform at Imperial Capital. 3. Flowers Foods (FLO) downgraded to Hold from Buy at Jefferies with analyst Akshay Jagdale saying his positive thesis on bread industry pricing becoming more rational has not played out. 4. AstraZeneca (AZN) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Vincent Meunier saying shares look fairly valued as he removed MYSTIC from his models. 5. U.S. Steel (X) downgraded to Sell from Neutral at Citi with analyst Alexander Hacking saying he sees downside risk to U.S. flat rolled prices for the remainder of 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
LMT Lockheed Martin
$299.20

-2.22 (-0.74%)

07/19/17
ARGS
07/19/17
NO CHANGE
ARGS
Lockheed Martin price target raised to $320 from $290 at Argus
Argus analyst John Eade increased his price target on Lockheed Martin after the company reported higher than expected Q2 EPS. The analyst notes that U.S. defense spending is rising, while geopolitical tensions are increasing. Calling the stock's valuation attractive, he keeps a Buy rating on the shares.
08/08/17
MSCO
08/08/17
INITIATION
Target $342
MSCO
Overweight
Lockheed Martin initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Rajeev Lalwani initiated Lockheed Martin with an Overweight and a $342 price target saying it has the right balance of segment margin growth, revenue visibility, and leading 5-year CAGR, all supported by the F-35 ramp over the coming years, combined with pension benefits.
08/14/17
SBSH
08/14/17
NO CHANGE
SBSH
Buy
Lockheed wins $8B contract over L3 and CACI, says Citi
Citi analyst Jason Gursky says the U.S. Special Ops Command Friday after the close awarded the Special Operations Forces Global Logistics Support Services contract to incumbent Lockheed Martin (LMT) over L3 Technologies (LLL), CACI (CACI) and potentially others. The $8B contract over multiple years is a positive development for Lockheed's MFC segment and an "incremental negative" for L3, the analyst tells investors in a research note. He believes CACI's bid "was always a long shot given the level of competition." Gursky has Buy ratings on all three names.
08/08/17
08/08/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Amazon.com (AMZN), Alphabet (GOOG, GOOGL), and Facebook (FB) were reinstated with a Buy at Mizuho, while eBay (EBAY) and Twitter (TWTR) were reinstated with an Underperform. 2. Broadridge (BR) initiated with a Neutral at DA Davidson. 3. Brighthouse Financial (BHF) initiated with an Overweight at Barclays. 4. Akcea Therapeutics (AKCA) WAS initiated with an Outperform at BMO Capital and Cowen, an Outperform at Wells Fargo, as well as a Buy at Stifel. 5. Lockheed Martin (LMT) and Raytheon (RTN) were initiated with an Overweight at Morgan Stanley, while Northrop Grumman (NOC) was initiated with an Equal Weight, and General Dynamics (GD) was initiated with an Underweight at the firm. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
GDI Gardner Denver
$21.97

-0.03 (-0.14%)

06/06/17
06/06/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Hartford Financial (HIG) initiated with a Buy at Deutsche Bank. 2. FedEx (FDX) and UPS (UPS) were initiated with a Neutral at Seaport Global. 3. Gardner Denver (GDI) was initiated with an Outperform at William Blair and Baird, an Overweight at Piper Jaffray, a Buy at Stifel, UBS, and Goldman Sachs, as well as a Neutral at Credit Suisse. 4. Solaris Oilfield (SOI) was initiated with an Outperform at Wells Fargo, Oppenheimer, Evercore ISI, and Credit Suisse, an Overweight at Piper Jaffray, as well as a Buy at Goldman Sachs and Wunderlich. 5. LeMaitre (LMAT) initiated with a Hold at Craig-Hallum. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/06/17
TIGR
06/06/17
INITIATION
TIGR
Buy
Gardner Denver initiated with a Buy at Tigress Financial
Tigress Financial analyst Ivan Feinseth initiated Gardner Denver with a Buy rating, citing its competitive advantage, installed base and growing aftermarket platform.
06/06/17
WBLR
06/06/17
INITIATION
WBLR
Outperform
Gardner Denver initiated with an Outperform at William Blair
William Blair analyst Brian Drab started Gardner Denver with an Outperform rating.
07/11/17
WOLF
07/11/17
INITIATION
Target $26
WOLF
Outperform
Gardner Denver initiated with an Outperform at Wolfe Research
Wolfe Research initiated Gardner Denver with an Outperform and a$26 price target.
CAH Cardinal Health
$64.38

-0.78 (-1.20%)

08/09/17
BARD
08/09/17
NO CHANGE
BARD
Neutral
AmerisourceBergen settlement ups odds of PharMerica switch, says Baird
Baird analyst Eric Coldwell said AmerisourceBergen's (ABC) 10-Q last week showed that the company and PharMerica (PMC) have tentatively agreed to settle their long-running legal fight, which he reads as significantly increasing the odds of AmerisourceBergen displacing incumbent Cardinal Health (CAH) after KKR (KKR) and minority investor Walgreens (WBA) complete their deal to buy PharMerica. Coldwell has a Neutral rating and $89 price target on AmerisourceBergen shares.
07/13/17
FBCO
07/13/17
NO CHANGE
Target $87
FBCO
Outperform
Cardinal Health price target raised to $87 from $81 at Credit Suisse
Credit Suisse analyst Erin Wilson Wright raised her price target for Cardinal Health to $87 from $81 given the company's recent acquisition of Medtronic's patient recovery business. The analyst reiterates an Outperform rating on the shares.
07/03/17
BARD
07/03/17
NO CHANGE
Target $75
BARD
Neutral
Cardinal Health confirms deal to buy Liberty Medical, says Baird
Baird analyst Eric Coldwell said that Cardinal Health has confirmed a deal to buy Liberty Medical, a direct-to-patient provider of diabetes supplies and products that is well known for its commercials featuring actor Wilford Brimley. The small deal, which is immaterial to his model, enhances Cardinal's direct-to-patient platform primarily in diabetes and likely also adds volume in ostomy and urology, Coldwell tells investors. He keeps a Neutral rating and $75 price target on Cardinal Health shares.
08/03/17
FBCO
08/03/17
NO CHANGE
Target $81
FBCO
Outperform
Cardinal Health price target lowered to $81 from $87 at Credit Suisse
Credit Suisse analyst Erin Wilson Wright lowered her price target for Cardinal Health to $81 from $87, citing on a "surprising" cut to 2018 EPS guidance primarily on incremental investment initiatives across its businesses, further defining 2018 as a transition year. The analyst reiterates an Outperform rating on the shares.
PDCO Patterson Companies
$36.45

-0.31 (-0.84%)

07/26/17
GSCO
07/26/17
NO CHANGE
GSCO
Dental survey indicates Q2 upside for Align, Henry Schein, says Goldman Sachs
Goldman analyst Robert Jones said checks indicate Q2 Dental trends remained stable and point to consistent low-single-digit growth end-markets. The analyst likes Align Technology (ALGN) saying Q2 case guidance appears beatable and expects high 20% case growth driven by investments, sees Q2 upside for Henry Schein (HSIC) due to share gains from Patterson Companies (PDCO), and said Dentsply Sirona (XRAY) promotions to drive cross-selling have yet to gain traction and 2017 guidance may be aggressive, but expectations are low into the quarter.
07/13/17
FBCO
07/13/17
NO CHANGE
Target $50
FBCO
Outperform
Patterson Companies price target raised to $50 from $45 at Credit Suisse
Credit Suisse analyst Erin Wilson Wright raised her price target for Patterson Companies to $50 from $45 to be more in line with industry peers. The analyst reiterates an Outperform rating on the shares.
08/17/17
CHLM
08/17/17
NO CHANGE
Target $41
CHLM
Hold
Patterson Companies price target lowered to $41 from $46 at Craig-Hallum
Craig-Hallum analyst Kevin Ellich lowered his price target for Patterson Companies(PDCO) to $41 from $46 to reflect the soft dental consumable environment and potential market share losses once Henry Schein (HSIC) starts to sell CEREC on September 1. Given the lower valuation and good, stable end markets, the analyst thinks Patterson Companies could be an "interesting target" for a financial buyer as cash flow should start to improve over the next few quarters once the company completes the ERP implementation. He reiterates a Hold rating on Patterson Companies' shares.
08/01/17
NRCS
08/01/17
NO CHANGE
Target $76
NRCS
Buy
Dentsply Sirona estimaters reduced at Northcoast
Northcoast analyst Ed Snyder's checks indicate Patterson Companies (PDCO) sales of high technology dental equipment is weaker than expected caused by industry competition. Snyder said it appears Patterson's CEREC sales growth is down about 40-50%, despite promotional activity. As a result, he reduced Dentsply Sirona's (XRAY) second half internal growth estimate to 1.4% from 2.3% and earnings FY17 earnings estimate to $2.80 from $2.82. Snyder retains a Buy rating on Dentsply and a $76 price target.
RMD ResMed
$73.07

0.28 (0.38%)

08/02/17
08/02/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Under Armour (UA, UAA) downgraded to Neutral from Buy at Citi with analyst Kate McShane citing yesterday's guide-down, the shares look "too expensive for investors to jump into the name nearer-term." 2. Burlington Stores (BURL) downgraded to Neutral from Outperform at Credit Suisse with analyst Christian Buss saying that although the fundamentals of the company remain healthy, he sees limited upside to valuation as the multiples stay elevated despite more moderate industry growth prospects. 3. Big 5 Sporting (BGFV) downgraded to Hold from Buy at Deutsche Bank with analyst Mike Baker saying he expected Big Five's sales gains following The Sports Authority liquidation would decelerate at some point, but he notes that "trends fell off faster and to a greater extent than we suspected." 4. Ultimate Software (ULTI) downgraded to Hold from Buy at Deutsche Bank with analyst Nandan Amladi calling the second quarter results "mixed" and prefers to move to the sidelines until growth returns to the mid-20s target and leverage returns to the model. 5. ResMed (RMD) was downgraded to Neutral from Buy at BofA/Merrill and to Neutral from Outperform at Credit Suisse. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/02/17
08/02/17
DOWNGRADE

Neutral
ResMed downgraded to Neutral at Credit Suisse
As previously reported, Credit Suisse analyst Saul Hadassin downgraded ResMed to Neutral from Outperform following the company's Q4 in line earnings. The analyst also lowered his price target on the shares to A$9.40 from A$9.70.
08/02/17
BOFA
08/02/17
DOWNGRADE
BOFA
Neutral
ResMed downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst William Dunlop downgraded ResMed to Neutral with a reduced price target of A$9.90. The analyst says the company's FY18 gross margin range of around 58.2% lessen his enthusiasm for its CPAP business prospects.
08/02/17
SBSH
08/02/17
UPGRADE
SBSH
Buy
ResMed upgraded to Buy from Neutral at Citi
Citi analyst Victor Windeyer upgraded ResMed to Buy with following the company's Q4 results. Credit Suisse and BofA/Merrill downgraded the shares this morning. The analyst believes supply bottlenecks have been removed and that the mask category can return to growth. He raised his price target for ResMed shares to A$10.50 from A$10.
ABC AmerisourceBergen
$78.60

-1.34 (-1.68%)

08/02/17
LEER
08/02/17
NO CHANGE
LEER
AmerisourceBergen may benefit from PharMerica takeover, says Leerink
Leerink analyst David Larsen believes AmerisourceBergen (ABC) could benefit from KKR's (KKR) buyout of PharMerica (PMC). KKR and Walgreens Boots Alliance (WBA), which uses AmerisourceBergen as a supplier, are forming a new private company which would hold PharMerica, Larsen tells investors in a research note. He believes PharMerica may switch away from its current supplier Cardinal Health (CAH) as a result of today's deal and use AmerisourceBergen. Any potential change in distributor contracts would likely occur in the second half of 2018, the analyst adds.
08/07/17
LEER
08/07/17
NO CHANGE
Target $90
LEER
Outperform
AmerisourceBergen price target lowered to $90 from $100 at Leerink
Leerink analyst David Larsen lowered his price target for AmerisourceBergen to $90 from $100 noting that while its Q3 earnings results were largely in-line with consensus and guidance, the stock has sold off due to a lack of clarity around guidance for 2018. Nonetheless, the analyst reiterates an Outperform rating on the shares.
07/13/17
FBCO
07/13/17
NO CHANGE
Target $105
FBCO
Outperform
AmerisourceBergen price target raised to $105 from $95 at Credit Suisse
Credit Suisse analyst Erin Wilson Wright raised her price target for AmerisourceBergen to $105 from $95 to be more in line with the distributor group average. The analyst reiterates an Outperform rating on the shares.
UNH UnitedHealth
$190.82

-1.88 (-0.98%)

08/16/17
PIPR
08/16/17
NO CHANGE
PIPR
Overweight
UnitedHealth made 'solid choice' in new CEO, says Piper Jaffray
Piper Jaffray analyst Sarah James views UnitedHealth's promotion of David Wichmann as a "solid choice and not a surprise." The analyst expects business as usual for the company as it continues to push into technology including artificial intelligence. She has an Overweight rating on the shares.
08/11/17
COWN
08/11/17
NO CHANGE
Target $220
COWN
Outperform
UnitedHealth price target raised to $220 from $175 at Cowen
Cowen analyst Christine Arnold raised her price target on UnitedHealth to $220 from $175. The analyst believes the company can achieve its long-term growth targets in 2018, citing Medicare Advantage enrollment growth, operating efficiencies, commercial market penetration, and OptumRx and OptumInsight earnings gains. Arnold reiterated her Outperform rating on UnitedHealth shares.
07/28/17
WELS
07/28/17
NO CHANGE
Target $9
WELS
Underperform
Insurers are dropping Valeant's top products, says Wells Fargo
United Healthcare's (UNH) formulary is no longer covering Valeant Pharmaceuticals' (VRX) number three branded drug Solodyn and will also now exclude Retin-A brand, its number four branded drug, Wells Fargo analyst David Maris tells investors in a research note. The analyst estimates the two drugs represented approximately $214M of Valeant's sales in 2016. Maris also points out that Glumetza, Valeant's number eight branded drug, and Relistor were removed in July from CVS/Caremark's (CVS) formulary. These two drugs had approximately $119M in 2016 revenues. Maris notes his counterpart Peter Costa estimates that United Healthcare covers approximately 17% of the U.S. and CVS covers approximately 33%. Express Scripts (ESRX) is releasing its 2018 national formulary next week, Costa adds. Maris keeps an Underperform rating on shares of Valeant with a $9 price target. The stock in premarket trading is down 33c, or 2%, to $16.80.
07/19/17
UBSW
07/19/17
NO CHANGE
Target $213
UBSW
Buy
UnitedHealth price target raised to $213 from $194 at UBS
UBS analyst A.J. Rice raised his price target on UnitedHealth to $213 from $194 following Q2 earnings. The analyst cited the company's positive outlook to gain market share in both group and individual Medicare Advantage markets along with continued growth assumptions for Optum Rx. Rice reiterated his Buy rating on UnitedHealth shares.
AAP Advance Auto Parts
$93.26

0.41 (0.44%)

08/16/17
GABE
08/16/17
NO CHANGE
GABE
Buy
Advance Auto Parts weakness a buying opportunity, says Gabelli
08/16/17
08/16/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Dick's Sporting (DKS) was downgraded to Neutral from Buy at Monness Crespi, Goldman Sachs, MKM Partners, Buckingham, Citi, and to Neutral from Positive at Susquehanna, while being downgraded to Hold from Buy at Deutsche Bank and to Sector Perform from Outperform at RBC Capital. 2. Teva (TEVA) downgraded to Neutral from Buy at Citi with analyst Liav Abraham saying Teva is "cheap, but not cheap enough." 3. Advance Auto Parts (AAP) downgraded to Neutral from Overweight at Atlantic Equities with analyst Sam Hudson citing limited near-term visibility. 4. SL Green Realty (SLG) and Kilroy Realty (KRC) were downgraded to Neutral from Buy at BofA/Merrill, while Gramercy Property Trust (GPT) was downgraded to Underperform from Neutral. 5. CB&I (CBI) downgraded to Hold from Buy at Jefferies with analyst Martin Englert saying he is concerned that cost overruns at the company's two LNG projects could reemerge, adding risk to 2017-2019 earnings. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/16/17
ATLE
08/16/17
DOWNGRADE
Target $93
ATLE
Neutral
Advance Auto Parts downgraded to Neutral from Overweight at Atlantic Equities
Atlantic Equities analyst Sam Hudson downgraded Advance Auto Parts to Neutral from Overweight with a $93 price target citing limited near-term visibility. Hudson said the challenging industry backdrop has pushed out a turnaround until FY18 at the earliest and said negative comps will persist in the second half and near-term margins are difficult to gauge.
08/16/17
DBAB
08/16/17
NO CHANGE
Target $101
DBAB
Buy
Deutsche Bank sticking with Buy rating on Advance Auto Parts
Deutsche Bank analyst Mike Baker lowered his price target to $101 from $139 following the Q2 results but is sticking with his Buy rating on Advance Auto Parts. First and most importantly, the company seems to be stabilizing its market share, the first step in any turnaround, Baker tells investors in a post-earnings research note. He also believes downward earnings revisions should be behind the company and that the current share price assumes little margin recovery.
MSI Motorola Solutions
$87.37

0.24 (0.28%)

05/30/17
NRCS
05/30/17
UPGRADE
NRCS
Buy
Motorola Solutions upgraded to Buy from Neutral at Northcoast
05/26/17
JEFF
05/26/17
NO CHANGE
Target $100
JEFF
Buy
Jefferies feels 'very good' about risk/reward on Motorola Solutions
After looking into the company's business, Jefferies analyst George Notter says he feels "very good" about the risk/reward in shares of Motorola Solutions. The company is not seeing any slowdown in its Federal business, and management tends to set conservative expectations, Notter tells investors in a research note. He's still surprised that the guidance three weeks ago wasn't viewed more positively. The analyst reiterates a Buy rating on Motorola Solutions with a $100 price target.
05/22/17
05/22/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded to Overweight from Neutral at JPMorgan with analyst Rod Hall saying while more negative news from the Apple (AAPL) royalty suit is likely, "material fundamental upside" exists from the closure of the NXP Semiconductors (NXPI) by the end of this year. The analyst views the deal as highly accretive. Hall also believes Apple ultimately will want to preserve its commercial relationship with Qualcomm. 2. Motorola Solutions (MSI) upgraded to Outperform from Market Perform at Raymond James with analyst Tavis McCourt saying shares look increasingly attractive based on improved demand visibility that is less economically sensitive than many of its peers, and demand catalysts from FirstNet buildouts that are expected to start in 2018. 3. Entegris (ENTG) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Toshiya Hari citing the recent pullback in shares and maintained a $29 price target. 4. Blackstone (BX) upgraded to Buy from Neutral at Citi with analyst William Katz saying the company's intentions to raise a $40B infrastructure fund should be a "valuation catalyst." 5. Cree (CREE) upgraded to Outperform from Market Perform at JMP Securities with analyst Joseph Osha saying he thinks that the company's new CEO could make positive changes at the company. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/22/17
RAJA
05/22/17
UPGRADE
Target $95
RAJA
Outperform
Motorola Solutions upgraded to Outperform on valuation at Raymond James
Raymond James upgraded Motorola Solutions to Outperform from Market Perform and established a $95 price target. Analyst Tavis McCourt said shares look increasingly attractive based on improved demand visibility that is less economically sensitive than many of its peers, and demand catalysts from FirstNet buildouts that are expected to start in 2018.
LGF.A Lionsgate
$28.41

0.37 (1.32%)

06/02/17
06/02/17
UPGRADE
Target $31

Buy
Lionsgate upgraded to Buy at SunTrust
As previously reported, SunTrust upgraded Lionsgate (LGF.B) to Buy from Hold and raised its price target to $31 from $28. Analyst Matthew Thornton said expectations into the Q4 report were cautious as evidenced by the stock reaction to earnings, despite FY18 OIBDA guidance that was 3% below consensus. Now that FY18 OIBDA, Motion Pictures, and TV Production expectations have been re-based, Thornton believes estimates are now achievable, and said Starz's upcoming original releases should help sub growth near-term. The analyst said deleveraging is ahead of plan and could result in buybacks in FY19, and continues to expect ongoing consolidation of content and distribution, making Lionsgate a target given its assets and size.
06/27/17
DBAB
06/27/17
INITIATION
Target $29
DBAB
Hold
Lionsgate initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Bryan Kraft started Lionsgate Class A (LGF.A) shares with a Hold rating and $29 price target. The analyst views consensus estimates as too high but sees potential upside through consolidation.
06/27/17
06/27/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. JPMorgan analyst Alex Yao resumed coverage of Alibaba (BABA) Group with an Overweight rating and $190 price target following a period of restriction. The rating is unchanged and the price target is raised from $140. 2. SunTrust analyst Terry Tillman initiated Salesforce (CRM) with a Buy and a $110 price target and views its as a core holding for large-cap investors. 3. Citi analyst Joel Beatty started Arena Pharmaceuticals (ARNA) with a Buy rating and $23 price target. 4. Deutsche Bank analyst Bryan Kraft started Lionsgate Class A (LGF.A) shares with a Hold rating and $29 price target. 5. Cantor Fitzgerald analyst Louise Chen assumed coverage of Amarin (AMRN) with an Overweight rating and $10 price target. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/21/17
07/21/17
NO CHANGE

Lionsgate price target raised to $36 from $29 at Loop Capital
Loop Capital analyst David Miller said that while Lionsgate shares have grinded higher as the company "continues to do what it has always done very well," he also has confidence that it is well ahead of plan on Starz synergies and that it has potential from "second-window" sales of streaming rights and orders from OTT platforms. Miller raised his price target on Lionsgate B shares to $36 from $29 and keeps a Buy rating on the name.
BGS B&G Foods
$31.40

-0.3 (-0.95%)

07/25/17
RBCM
07/25/17
NO CHANGE
RBCM
B&G Foods weakness overdone, says RBC Capital
RBC Capital analyst David Palmer says that B&G Foods' 15% decline this year is overdone. The analyst says that B&G's "category exposure may be better than peers," as it is more exposed to vegetables and spices, is the leader in Hispanic food categories and has "best in class spice manufacturing capacity." The analyst believes that scanner data understates the company's recent performance and outlook,. Additionally, he believes that its 5% dividend yield has "limited risk," The analyst keeps a $52 price target and an Outperform rating on the stock.
07/20/17
07/20/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Nike (NKE) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Jay Sole saying the window to buy Nike is closing as earnings and North America sales growth rates are likely troughing. 2. B&G Foods (BGS) upgraded to Buy from Neutral at Citi with analyst Cornell Burnett saying the second quarter should mark a positive inflection in organic sales after five consecutive quarters of declines. 3. HP Inc. (HPQ) upgraded to Outperform from Sector Perform at RBC Capital with analyst Amit Daryanani saying he sees a "string of beats/raises" ahead amid stabilizing PC fundamentals and market share gains as Lenovo struggles. 4. Royal Caribbean (RCL) upgraded to Overweight from Neutral at JPMorgan with analyst Joseph Greff saying he views the current valuation as "undemanding" and notes his recent channel checks suggest continued good operating momentum. 5. Buffalo Wild Wings (BWLD) upgraded to Neutral from Underperform at Wedbush with analyst Nick Setyan saying investors understand that the company could report weaker than expected results and his other concerns about the company "are well understood." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/20/17
SBSH
07/20/17
UPGRADE
Target $43
SBSH
Buy
B&G Foods upgraded to Buy from Neutral at Citi
Citi analyst Cornell Burnett upgraded B&G Foods to Buy saying Q2 should mark a positive inflection in organic sales after five consecutive quarters of declines. The analyst projects flat organic sales, driven by strong growth in Green Giant, and views the current valuation as "cheap." Burnett keeps a $43 price target for the shares.
08/07/17
BMOC
08/07/17
UPGRADE
BMOC
Outperform
B&G Foods upgraded to Outperform from Market Perform at BMO Capital
BMO Capital analyst Kenneth Zaslow upgraded B&G based on valuation. Target $39.
MDLZ Mondelez
$42.94

-0.47 (-1.08%)

06/19/17
FBCO
06/19/17
NO CHANGE
FBCO
Hershey buy of Nestle assets could be type of 'poison pill,' says Credit Suisse
Credit Suisse analyst Robert Moskow analyzed several scenarios after Nestle's (NSRGY) recent announcement of a strategic review of its U.S. confectionery business. Buying Nestle candy would double Mondelez's (MDLZ) U.S. market share to 10%, but Moskow wonders if such a deal could compromise Mondelez' ability to eventually buy Hershey (HSY) at a later date. As for the latter, Hershey would generate "massive" synergies of 9% of sales and the deal could work as a type of "poison pill" to deter a bid from Mondelez or Kraft Heinz (KHC), said Moskow. However, he doesn't think Hershey would want to buy an asset that would dilute its topline growth rate at this point. He added that he sees "little to no chance" of Lindt, the number three in U.S. candy, being interested in Nestle's assets.
07/25/17
07/25/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Mondelez (MDLZ) upgraded to Overweight from Neutral at Piper Jaffray with analyst Michael Lavery saying favorable sugar and cocoa costs provide a boost to margins. 2. Big Lots (BIG) upgraded to Buy from Hold at Deutsche Bank analyst Paul Trussell saying the current valuation is "compelling" given the disconnect between the company's "impressive" operating profit growth and multiple. 3. Werner (WERN) upgraded to Neutral from Underperform at BofA/Merrill with analyst Ken Hoexter saying truckload utilization and rates are turning positive. 4. Atlassian (TEAM) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Sanjit Singh saying has increased confidence in expansion trends of the user base and said there are clear signs of pricing power, supporting 30% topline growth and 40% free cash flow CAGR over the next 3 years. 5. DSW (DSW) upgraded to Buy from Hold at Deutsche Bank with analyst Paul Trussell saying the shares offer an "intriguing non-apparel value play." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/03/17
WELS
08/03/17
NO CHANGE
WELS
Mondelez new CEO 'unconventional' but can 'inject fresh ideas,' says Wells Fargo
After Mondolez announced that its CEO would resign and named Dirk Van de Put as her successor, Wells Fargo calls the choice "unconventional." However, the firm thinks that, as an outsider, he will be able to "inject fresh ideas." Wells keeps an Outperform rating on the shares.
07/25/17
PIPR
07/25/17
UPGRADE
Target $49
PIPR
Overweight
Mondelez upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Michael Lavery upgraded Mondelez to Overweight and raised his price target for the shares to $49 from $48. Favorable sugar and cocoa costs provide a boost to margins, Lavery tells investors in a research note. The analyst expects the company's cash build will be applied to buybacks.
SRE Sempra Energy
$116.55

0.76 (0.66%)

06/08/17
LEHM
06/08/17
DOWNGRADE
Target $121
LEHM
Equal Weight
Sempra Energy downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Daniel Ford downgraded Sempra Energy (SRE) to Equal Weight with the shares close to his unchanged price target of $121. The analyst is increasingly concerned that the Cameron LNG export facility could face construction delays given the project's association with CB&I (CBI).
BRK.A Berkshire Hathaway
$267,377.00

302 (0.11%)

07/12/17
LOOP
07/12/17
NO CHANGE
Target $42
LOOP
Buy
Core-Mark unlikely to 'get Amazoned,' says Loop Capital
Loop Capital analyst Andrew Wolf said he sees Core-Mark (CORE) as the least likely company among those he covers to get "Amazoned," or put at risk by Amazon (AMZN) buying a competitor. Its closest competitor McLane, which is owned by Berkshire Hathaway (BRK.B), is highly unlikely to sell to Amazon given that its largest customer is Amazon's rival Wal-Mart (WMT), Wolf tells investors. He keeps a Buy rating on Core-Mark and raised his target on the shares to $42 from $40 citing his increased 2018 EPS forecast.
06/27/17
06/27/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Impinj (PI) was downgraded to Sector Weight from Overweight by Pacific Crest analyst Brad Erickson based on valuation. 2. Mizuho analyst Haendel St. Juste downgraded Store Capital (STOR) to Neutral from Buy citing fair valuation following recent strength driven by Berkshire Hathaway's (BRK.A) investment. 3. Camtek (CAMT) was downgraded to Hold from Buy by Needham analyst Y. Edwin Mok, as he expects to see some deceleration as the PCB business normalizes and he believes large orders for back-end semi inspections are already reflected in the stock after its recent run-up. 4. Nomura Instinet analyst Dan Dolev downgraded Cintas (CTAS) to Neutral from Buy after lowering his FY18 uniform rental organic growth forecasts to 5% from 7%. 5. Atlantic Equities analyst Barry MacCarthy downgraded Hess Corp. (HES) and Schlumberger (SLB), both to Neutral from Overweight, given his view of the limited prospects for an oil price rebound. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/16/17
MSCO
05/16/17
NO CHANGE
Target $212
MSCO
Overweight
IBM at attractive entry point ahead of mainframe cycle, says Morgan Stanley
Morgan Stanley analyst Katy Huberty attributes recent weakness in shares of IBM (IBM) to the combination of the news that Warren Buffett's Berkshire Hathaway (BRK.A) cut its stake by a third and the company's weak Q1 gross margin trends. However, growth accelerates and margins expand historically for IBM around a mainframe cycle, making the pullback an attractive entry point, according to Huberty. The analyst, who sees a number of the gross margin pressures that have recently plagued IBM abating in the second half of 2017, has a $212 price target on Big Blue's shares.
03/20/17
03/20/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Monness Crespi analyst James Cakmak initiated Snap (SNAP) with a Buy and a $25 price target. 2. Workday (WDAY) initiated with a Buy at BofA/Merrill. 3. Berkshire Hathaway (BRK.A) initiated with an Equal Weight at Morgan Stanley. 4. MeetMe (MEET) initiated with a Buy at Canaccord. 5. ARC Document (ARC) resumed with a Buy at B. Riley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

14:51
09/19/17
09/19
14:51
09/19/17
14:51
General news
Mexico Bolsa market halts trading following earthquake, Bloomberg reports »

Equities, fixed income,…

FDX

FedEx

$215.92

0.84 (0.39%)

14:49
09/19/17
09/19
14:49
09/19/17
14:49
Options
Fedex options imply 4.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 21

    Sep

  • 25

    Sep

UBNT

Ubiquiti

$50.62

-4.335 (-7.89%)

14:47
09/19/17
09/19
14:47
09/19/17
14:47
Technical Analysis
Technical View: Ubiquiti heading down in late afternoon trading »

The shares have been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Nov

VLO

Valero

$72.67

0.47 (0.65%)

14:44
09/19/17
09/19
14:44
09/19/17
14:44
Periodicals
Valero says responding to fire at Port Arthur refinery, Reuters reports »

Valero has confirmed that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

UBNT

Ubiquiti

$50.62

-4.335 (-7.89%)

14:42
09/19/17
09/19
14:42
09/19/17
14:42
Recommendations
Ubiquiti analyst commentary  »

Most Citron points on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Nov

REV

Revlon

$17.15

1.15 (7.19%)

14:40
09/19/17
09/19
14:40
09/19/17
14:40
Hot Stocks
Revlon jumps after majority shareholder Perelman says won't take private »

Shares of personal care…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLNG

Golar LNG

$21.04

-0.41 (-1.91%)

14:35
09/19/17
09/19
14:35
09/19/17
14:35
Options
Golar LNG put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWW

iShares MSCI Mexico

$55.84

-0.07 (-0.13%)

14:31
09/19/17
09/19
14:31
09/19/17
14:31
Hot Stocks
Breaking Hot Stocks news story on iShares MSCI Mexico »

iShares MSCI Mexico dips…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICON

Iconix Brand

$5.88

0.19 (3.34%)

14:29
09/19/17
09/19
14:29
09/19/17
14:29
Initiation
Iconix Brand initiated  »

Iconix Brand initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

14:26
09/19/17
09/19
14:26
09/19/17
14:26
General news
Puebla, Mexico hit by 7.1 magnitude earthquake »

Reported by…

$NSD

NASDAQ Market Internals

14:17
09/19/17
09/19
14:17
09/19/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAIC

SAIC

$64.20

0.92 (1.45%)

14:16
09/19/17
09/19
14:16
09/19/17
14:16
Hot Stocks
SAIC moving into initial production phase for Marines' AAV SU program »

The U.S. Marine Corps…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
09/19/17
09/19
14:16
09/19/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNIT

Uniti Group

$17.47

-0.93 (-5.05%)

14:15
09/19/17
09/19
14:15
09/19/17
14:15
Options
Uniti Group put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

POR

Portland General Electric

$46.57

0.21 (0.45%)

14:15
09/19/17
09/19
14:15
09/19/17
14:15
Recommendations
Portland General Electric analyst commentary  »

Portland General Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOLVY

Volvo

14:01
09/19/17
09/19
14:01
09/19/17
14:01
Periodicals
Volvo to expand South Carolina production plant, CNBC reports »

Volvo is adding an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PETS

PetMed Express

$35.81

0.25 (0.70%)

13:55
09/19/17
09/19
13:55
09/19/17
13:55
Hot Stocks
PetMed lower after unverified Twitter user mentions SEC investigation »

Unverified Twitter user…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBY

Best Buy

$53.68

-3.6695 (-6.40%)

13:55
09/19/17
09/19
13:55
09/19/17
13:55
Conference/Events
Best Buy to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 22

    Oct

XOP

SPDR Oil Exploration and Production Fund

$32.01

-0.1011 (-0.31%)

13:50
09/19/17
09/19
13:50
09/19/17
13:50
Options
Call buying in SPDR Oil Exploration and Production ETF »

Call buying in SPDR Oil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOSBF

Toshiba, also use TOSYY

$2.88

-0.0001 (-0.00%)

, TOSYY

Toshiba, also use TOSBF

$17.25

-0.1699 (-0.98%)

13:49
09/19/17
09/19
13:49
09/19/17
13:49
Periodicals
Toshiba back to favoring Western Digital group for chip unit sale, Reuters says »

Toshiba (TOSBF, TOSYY) …

TOSBF

Toshiba, also use TOSYY

$2.88

-0.0001 (-0.00%)

TOSYY

Toshiba, also use TOSBF

$17.25

-0.1699 (-0.98%)

WDC

Western Digital

$89.18

0.66 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSTI

ShotSpotter

$10.88

0.01 (0.09%)

13:46
09/19/17
09/19
13:46
09/19/17
13:46
Hot Stocks
ShotSpotter announces expansion to seven new U.S. cities »

ShotSpotter, which makes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLO

Valero

$73.10

0.9 (1.25%)

13:45
09/19/17
09/19
13:45
09/19/17
13:45
Periodicals
Crews battling fire at Valero refinery in Port Arthur, News4SA reports »

Crews are battling a fire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

GIS

General Mills

$55.32

-1.11 (-1.97%)

13:34
09/19/17
09/19
13:34
09/19/17
13:34
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

WDC

Western Digital

$89.18

0.66 (0.75%)

, TOSBF

Toshiba, also use TOSYY

$2.88

-0.0001 (-0.00%)

13:34
09/19/17
09/19
13:34
09/19/17
13:34
Hot Stocks
Breaking Hot Stocks news story on Western Digital, Toshiba, also use TOSYY, Toshiba, also use TOSBF »

Western Digital jumps 1%…

WDC

Western Digital

$89.18

0.66 (0.75%)

TOSBF

Toshiba, also use TOSYY

$2.88

-0.0001 (-0.00%)

TOSYY

Toshiba, also use TOSBF

$17.25

-0.1699 (-0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$155.77

1.28 (0.83%)

, FDX

FedEx

$215.84

0.76 (0.35%)

13:34
09/19/17
09/19
13:34
09/19/17
13:34
Earnings
Notable companies reporting after market close »

Notable companies…

ADBE

Adobe

$155.77

1.28 (0.83%)

FDX

FedEx

$215.84

0.76 (0.35%)

CPRT

Copart

$32.86

0.34 (1.05%)

BBBY

Bed Bath & Beyond

$27.30

-1.37 (-4.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

  • 25

    Sep

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.